c-DNA vaccination against parasitic infections: advantages and disadvantages
Veterinary Parasitology, ISSN: 0304-4017, Vol: 100, Issue: 1, Page: 3-12
2001
- 25Citations
- 39Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations25
- Citation Indexes25
- 25
- CrossRef15
- Captures39
- Readers39
- 39
Article Description
Recently developed technology for DNA vaccination appears to offer the good prospect for the development of a multivalent vaccines that will effectively activate both the humoral and cell mediated mechanisms of the immune system. Currently, DNA vaccination against such important parasitic diseases like malaria, leishmaniosis, toxoplasmosis, cryptosporidiosis, schistosomosis, fasciolosis offers several new opportunities. However, the outcome of vaccination depends very much on vaccine formulations, dose and route of vaccine delivery, and the species and even strain of the vaccinated host. To overcome these problems much research is still needed, specifically focused on cloning and testing of new c-DNA sequences in the following: genome projects: different ways of delivery: design of vectors containing appropriate immunostimulatory sequences and very detailed studies on safety.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0304401701004782; http://dx.doi.org/10.1016/s0304-4017(01)00478-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0035850547&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11522401; https://linkinghub.elsevier.com/retrieve/pii/S0304401701004782; http://linkinghub.elsevier.com/retrieve/pii/S0304401701004782; http://api.elsevier.com/content/article/PII:S0304401701004782?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0304401701004782?httpAccept=text/plain; http://dx.doi.org/10.1016/s0304-4017%2801%2900478-2; https://dx.doi.org/10.1016/s0304-4017%2801%2900478-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know